LCN2 and chronic kidney disease: In patients with CKD, overexpression of NGAL occurs in renal tubular cells, compared with its expression among non-CKD patients [18], and both serum and urinary NGAL represent a novel, independent renal predictor of the severity of renal disease and CKD progression [19].